MCMT
AZN icon

Moon Capital Management (Tennessee)’s AstraZeneca AZN Stock Holding History

Moon Capital Management (Tennessee)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,616
Closed -$1.01M – 41
2014
Q1 		$1.01M Buy
15,616
+3
+0% +$194 1.37% 21
2013
Q4 		$927K Sell
15,613
-575
-4% -$31.2K 1.33% 22
2013
Q3 		$841K Buy
+16,188
New +$813K 1.2% 26

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Moon Capital Management (Tennessee)'s AZN Position: Q2 2014 in Review

Moon Capital Management (Tennessee) sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 15,616 shares — an estimated $1.01M sold.

Moon Capital Management (Tennessee) first reported a position in AZN in Q3 2013 and held it in 3 quarters. The position peaked at $1.01M in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

  • Moon Capital Management (Tennessee) reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
  • Moon Capital Management (Tennessee) sold 15,616 AstraZeneca shares in Q2 2014, an estimated $1.01M.
  • Moon Capital Management (Tennessee) first reported a position in AstraZeneca in Q3 2013 and held it in 3 quarters.
  • Moon Capital Management (Tennessee)'s AstraZeneca position peaked at $1.01M in Q1 2014.
  • 419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Moon Capital Management (Tennessee)'s 13F filing for Q2 2014, filed 14 Jul 2014.